SYDNEY: Anagenics Limited (ASX: AN1) has appointed Matthew Dudek as Acting Chief Executive Officer, effective 28 February 2022. Maria Halasz has resigned as CEO and Managing Director of Anagenics Limited, effective on the same date. Matthew has been the Company’s Group Financial Controller since the beginning of 2020. He is a graduate from the University…